Secondary Recommendation

Warpaint - Going global following IPO

January 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Cosmetics business Warpaint (W7L;137.5p) joined AIM last month and looks full of potential. The company was established in 1992 by Sam Bazini and Eoin Macleod when it started off life selling cosmetics and fragrances to discounters and chemists, which it sourced directly from the star names such as Revlon, Max Factor and Calvin Klein. That “close out” market is for branded articles supplied by sources such as duty free shops, that have over-ordered.But changes in that marketplace in 2002 saw the duo take the big step of launching their own cosmetic range, under the W7 brand, which they began selling alongside the close out products, targeting the US$57bn global cosmetics market. W7 now accou ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Innovaderma - An enigma

Tarsus - Buys US travel event organiser

Warpaint (October 2024)

Warpaint - Barnstorming 500bps improvement in operating margin (May 2024)

Warpaint (February 2024)

Warpaint (December 2023)

Warpaint (July 2023)

Warpaint - Forecast busting outlook (May 2023)

Warpaint (April 2023)

Warpaint (February 2023)

Warpaint - Forecasts upgraded as international growth comes through (October 2022)

Warpaint (October 2019)

Warpaint (October 2018)

Warpaint (September 2018)

Warpaint (July 2018)

Warpaint - Eps forecast of 13.6p lifting to 16.7p (June 2018)

Warpaint - £21m cosmetic acquisition (December 2017)

Warpaint (October 2017)

Warpaint - US sales going gangbusters (August 2017)

Warpaint (July 2017)

Warpaint (June 2017)

Warpaint -Notes from meeting with Finance Director (April 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X